Compare AANJANEYA LIFECARE with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS PFIZER DR. DATSONS LABS/
PFIZER
 
P/E (TTM) x -10.9 32.7 - View Chart
P/BV x 0.2 5.5 3.0% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 DR. DATSONS LABS   PFIZER
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
PFIZER
Mar-18
DR. DATSONS LABS/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1262,365 5.3%   
Low Rs311,625 1.9%   
Sales per share (Unadj.) Rs133.0430.3 30.9%  
Earnings per share (Unadj.) Rs0.278.7 0.2%  
Cash flow per share (Unadj.) Rs6.693.2 7.1%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Dividend yield (eoy) %01.0 0.0%  
Book value per share (Unadj.) Rs128.8586.5 22.0%  
Shares outstanding (eoy) m31.6645.75 69.2%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.6 12.7%   
Avg P/E ratio x516.125.3 2,036.1%  
P/CF ratio (eoy) x11.821.4 55.3%  
Price / Book Value ratio x0.63.4 17.9%  
Dividend payout %025.4 0.0%   
Avg Mkt Cap Rs m2,47791,271 2.7%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m563,143 1.8%   
Avg. sales/employee Rs ThNM7,484.8-  
Avg. wages/employee Rs ThNM1,195.0-  
Avg. net profit/employee Rs ThNM1,369.1-  
INCOME DATA
Net Sales Rs m4,21119,685 21.4%  
Other income Rs m791,143 6.9%   
Total revenues Rs m4,28920,828 20.6%   
Gross profit Rs m5695,003 11.4%  
Depreciation Rs m204663 30.9%   
Interest Rs m4304 10,242.9%   
Profit before tax Rs m135,479 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,878 0.3%   
Profit after tax Rs m53,601 0.1%  
Gross profit margin %13.525.4 53.1%  
Effective tax rate %48.034.3 140.1%   
Net profit margin %0.118.3 0.6%  
BALANCE SHEET DATA
Current assets Rs m6,85224,167 28.4%   
Current liabilities Rs m6,7119,544 70.3%   
Net working cap to sales %3.374.3 4.5%  
Current ratio x1.02.5 40.3%  
Inventory Days Days16155 292.0%  
Debtors Days Days31829 1,109.6%  
Net fixed assets Rs m3,6739,514 38.6%   
Share capital Rs m317458 69.2%   
"Free" reserves Rs m3,76126,375 14.3%   
Net worth Rs m4,07826,832 15.2%   
Long term debt Rs m1,67125 6,683.2%   
Total assets Rs m12,63336,900 34.2%  
Interest coverage x1.01,305.5 0.1%   
Debt to equity ratio x0.40 43,978.8%  
Sales to assets ratio x0.30.5 62.5%   
Return on assets %3.49.8 35.2%  
Return on equity %0.113.4 0.9%  
Return on capital %7.720.4 37.6%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96422 4,303.6%   
Fx outflow Rs m6071,489 40.8%   
Net fx Rs m357-1,466 -24.3%   
CASH FLOW
From Operations Rs m1,3453,318 40.5%  
From Investments Rs m-2,256-2,383 94.7%  
From Financial Activity Rs m-1,200-1,104 108.7%  
Net Cashflow Rs m-2,111-169 1,252.6%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 0.0 7.5 -  
FIIs % 1.4 4.9 27.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 23.7 397.0%  
Shareholders   20,807 85,207 24.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   GLENMARK PHARMA  FULFORD INDIA  PROCTER & GAMBLE HEALTH  DIVIS LABORATORIES  UNICHEM LAB  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS